SBFM vs SEPN

Sunshine Biopharma Inc. vs Septerna, Inc. — Valuation Comparison 2026

SBFM

Pharmaceutical Preparations
Sunshine Biopharma Inc.
Quality
5.8
out of 10
Value Trap
24
SAFE
Price
$0.25
Last close
Models
2/13
Active
VS

SEPN

Pharmaceutical Preparations
Septerna, Inc.
Quality
7.0
out of 10
Value Trap
12
SAFE
Price
$30.20
Last close
Models
10/13
Active

Model-by-Model Comparison

ModelType SBFM Fair ValueSBFM Upside SEPN Fair ValueSEPN Upside
Bayesian DCF Intrinsic $0.89 +249.2% $15.60 -48.3%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $4.39 -85.5%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $5.98 +466.8% $29.16 -3.5%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for SBFM vs SEPN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SBFM vs SEPN — Which Stock Is More Undervalued?

SEPN scores higher with a 7.0/10 quality rating vs SBFM's 5.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Sunshine Biopharma Inc. (SBFM) and Septerna, Inc. (SEPN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SBFM currently trades at $0.25 with a QOC of 5.8/10, while SEPN trades at $30.20 with a QOC of 7.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).